Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2020
Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors
Yongbin Tian, Zhouling Xie, Chenzhong Liao
Future Medicinal Chemistry
|
October 7, 2024
Selective factor XI/XIa inhibitors: a beacon of hope in anticoagulation therapy
Zhouling Xie, Qin Wang, Chenzhong Liao
Future Medicinal Chemistry
|
April 3, 2020
Developing polo-like kinase 1 inhibitors
Xufeng Huang, Zhouling Xie, Chenzhong Liao
Drug Discovery Today
|
February 22, 2025
Drugs targeting peroxisome proliferator-activated receptors
Zhouling Xie, Jiwei Xin, Chuping Huang, et al.
European Journal of Medicinal Chemistry
|
February 18, 2020
Discovery and development of plasma kallikrein inhibitors for multiple diseases
Zhouling Xie, Zhen Li, Yanruisheng Shao, et al.
Future Medicinal Chemistry
|
June 21, 2017
The progress in the research of antiplatelet agents (1995-2017)
Oscar Benimana, Lulu Zhao, Yi Kong, et al.
Journal of Pharmacological Sciences
|
April 28, 2015
LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa
Yi Kong, Ying Wang, Wei Yang, et al.
Future Medicinal Chemistry
|
January 31, 2018
Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors
Zhouling Xie, Lulu Zhao, Xue Ding, et al.
Future Medicinal Chemistry
|
July 2, 2015
Progress in the research of GPIIb/IIIa antagonists
Zhouling Xie, Chen Cao, Sen Feng, et al.
Mini Reviews in Medicinal Chemistry
|
June 3, 2022
Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review
Yang Shu, Yajing Liu, Shirong Bian, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2020
Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors
Yongbin Tian, Zhouling Xie, Chenzhong Liao
Future Medicinal Chemistry
|
October 7, 2024
Selective factor XI/XIa inhibitors: a beacon of hope in anticoagulation therapy
Zhouling Xie, Qin Wang, Chenzhong Liao
Future Medicinal Chemistry
|
April 3, 2020
Developing polo-like kinase 1 inhibitors
Xufeng Huang, Zhouling Xie, Chenzhong Liao
Drug Discovery Today
|
February 22, 2025
Drugs targeting peroxisome proliferator-activated receptors
Zhouling Xie, Jiwei Xin, Chuping Huang, et al.
European Journal of Medicinal Chemistry
|
February 18, 2020
Discovery and development of plasma kallikrein inhibitors for multiple diseases
Zhouling Xie, Zhen Li, Yanruisheng Shao, et al.
Future Medicinal Chemistry
|
June 21, 2017
The progress in the research of antiplatelet agents (1995-2017)
Oscar Benimana, Lulu Zhao, Yi Kong, et al.
Journal of Pharmacological Sciences
|
April 28, 2015
LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa
Yi Kong, Ying Wang, Wei Yang, et al.
Future Medicinal Chemistry
|
January 31, 2018
Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors
Zhouling Xie, Lulu Zhao, Xue Ding, et al.
Future Medicinal Chemistry
|
July 2, 2015
Progress in the research of GPIIb/IIIa antagonists
Zhouling Xie, Chen Cao, Sen Feng, et al.
Mini Reviews in Medicinal Chemistry
|
June 3, 2022
Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review
Yang Shu, Yajing Liu, Shirong Bian, et al.
Page
of 5